Are Naysayers Right About Aphria (TSX:APHA)?

Is Aphria Inc. (TSX:APHA)(NYSE:APHA) over the hump and ready to contradict cynics’ prediction that the weed stock is not a good investment?

question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aphria (TSX:APHA)(NYSE:APHA) is no stranger to controversies and negative publicity. Shares of the cannabis company started tumbling in early December because of alleged insiders’ mischief.

A short-seller contends that Aphria is only a shell game with a marijuana business on the side. The charge was that the company bought its LATAM assets at inflated prices.

After the Ontario Securities Commission found that the assets had lower margins and higher-than-expected expenses, Aphria was meted a non-cash impairment charge of $50 million.

The company’s woes did not stop there. In February 2019, Green Growth Brands made an unsolicited buy offer, which Aphria’s board rejected, claiming the offer undervalued the company. These issues and more led cynics to say that Aphria has a slim chance of recovering lost ground.

Aphria was able to prove the prophets of doom wrong. APHA is the best cannabis stock to buy if you want exposure in the fastest-growing industry today.

Know your risk tolerance

This is the year of the cannabis sector. The industry itself, however, is extremely volatile. You must have a high tolerance for risk if you want to invest in marijuana stocks. The first question is, how much capital are you willing to risk in weed stock like Aphria?

Let’s look at the stock performance to understand the attendant risks. APHA was trading at $10.51, then dropped by 52.42% to $5 due to the short-seller’s issue. When the hostile bid came in February, the price rose to $14.21, or a gain of 184.2%.

APHA started sliding when the company’s board rejected the offer. On August 1, the day Aphria would present its latest quarterly earnings, the stock closed at $6.90. With Aphria’s surprise profits, the price spiked 40.14% to $9.67.

Clearly, the price swings are news driven. As of this writing, APHA is trading at $9.07. The erratic price movements reflect the cannabis sector’s extreme volatility. Nearly all cannabis companies are experiencing wild price swings.

If you don’t have a high-risk appetite, weed stocks are not the right investments for you.

High risk = high reward 

Weed stocks offer tremendous earnings opportunities. But as in any investments, the higher the rewards, the higher are the risks. With Aphria’s surprise profit, it’s the most profitable weed stock today, although it remains a risky investment.

Aphria has several catalysts to drive growth in the coming months. The company’s newly expanded area planted more than 200,000 plants. The 100-acre Aphria Diamond is awaiting Health Canada’s licensing approval.

Once Aphria obtains full licences, its production capacity could swell to 255,000 kilograms. Aside from Canada, the company can cultivate marijuana in Germany after the government gave Aphria the maximum number of lots.

Another tailwind is the market for vapes and concentrates, which Aphria forecasts to represent 30% of Canada’s adult-use market by 2021.

Go slow on weed stocks

Aphria’s interim CEO Irwin Simon recently said, “We had our customers, consumers, shareholders, employees all mad at us. I had to pull everyone together.” His statement seems to suggest that Aphria is not yet back on track.

Analysts are projecting an upside of 186.65% in the next 12 months. Aphria is the perfect example of a high-risk and high-reward stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »